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Traditionally, the primary focus of medical research is the measurement of mortality and morbidity. During the past decade however, interest is increasing in measurement of quality of life, health status, and functional status. Particularly in the field of chronic disease, it has been argued that greater attention should be paid to the impact of illness and treatment on the functional, emotional, and social wellbeing of a patient.
Parkinson's disease has a major adverse impact on patient's lives. Patients Other items were added to the item reduction questionnaire, based on the personal experience of neurologists specialised in Parkinson's disease (n = 3); the personal experience of the board of the Dutch Parkinson's Disease Society (a patient and a relative, n = 2); a review of the medical literature concerning the problems of patients with Parkinson's disease; and other disease specific instruments."l 13 1' Once this item reduction questionnaire had been generated, 13 consecutive patients of the outpatients' and inpatients' clinic of the Academic Medical Hospital of the University of Amsterdam were asked which of the 73 items had been a problem for them in the past three months. They were then asked to rate the importance of each item they had identified, using a five point Likert scale from "not very important" to "extremely important". The items chosen most often or rated most important were included in the Parkinson's disease quality of life (PDQL) questionnaire. 529 members by systematic sampling of zip codes (every eighth member on the list). We sent self report questionnaires to these 529 patients. In all, 450 questionnaires were returned (85-1 %). Of these, 66 (14-6%) were not completed, mainly because the member was deceased (7 5% of the returned questionnaires), because the patient was physically unable (2%), or the patient was cognitively impaired (0-9%). Consequently, 384 questionnaires (85-3% of the returned, 72-6% of the total) could be used for data analysis.
Measurements
Standard demographic questions were used to assess sex, age, and other background variables. Factors related to parkinsonism and reported at the time of the survey included duration of disease (years since diagnosis); severity of disease as measured by the Schwab and England activities of daily living scale (10 categories) 5; and medication.
To assess daily physical, emotional, and social functioning the medical outcome studies-24 (MOS-24), a "generic" (disease nonspecific) quality of life instrument, was used.
The MOS-24 is a standardised measure of quality of life and is widely used for medical patients."' 'b '8 Seven subscales cluster 24 , and 80% were combined as group 1 (being independent, activities a bit slower); groups 70% and 60% were combined as group 2 (being slightly dependent, activities considerably slower); and groups 50%, 40%, 30%, 20%, and 10% were combined as group 3 (being dependent, needing help or care). Group 1 consisted of 171 patients, group 2 of 127 patients, and group 3 of 82 patients. It was hypothesised that severity of disease would clearly discriminate between the parkinsonian and systemic scores, but less clearly between the emotional and social scores of the PDQL. In the case of a significant effect, the Scheffe test for multiple comparison was performed to test for differences between the different Schwab and England groups.
To evaluate the convergent validity-that is, the extent to which the questionnaire is able to measure what it claims to measure, productmoment correction coefficients were calculated to assess linear relations between the PDQL and the three generic indices of quality of life. It was expected that conceptually related scales would correlate substantially (Pearson's r > 0 40).
Results

PHASE 1: ITEM SELECTION AND REDUCTION
The item reduction questionnaire was completed by 13 consecutive patients: four admitted patients and nine outpatients (six women and seven men; mean age 61 31 years). The figure gives the item mean scores of the four PDQL subscales. As expected, all scores were systematically lower (indicating poorer quality of life) in groups with higher disease severity (P < 0-001). For the overall PDQL, patients in group 1 (independent, activities a bit slower) had a mean score of 137, patients in group 2 (slightly dependent, activities considerably slower) had a mean score of 118, and patients in group 3 (dependent, needing help or care) had a mean score of 98.
The scores of the parkinsonian, systemic, emotional, and social function subscales followed a similar pattern. As expected, patients with higher disease severity had lower scores on the Parkinson (P < 0-001) and the systemic scale (P < 0-001). Moreover, they also had lower scores on the emotional (P < 0 001) and the social scales (P < 0-001). The scores of each of the three groups were significantly different from the scores of the other two groups on all four subscales and on the total PDQL scale (Scheffe procedure, all possible pairs of groups P < 0 05). PDQL scores by disease severity (DS). ANOVAs comparing mean PDQL scores for patients in the three disease severity (DS) groups: P < 0-001 for all PDQL scores. Higher scores represent better quality of life. Completely dependent (DS1, n = 171); somewhat dependent (DS2, n = 127); dependent (DS3, n = 82). Table 4 shows the matrices of productmoment correlation coefficients for PDQL subscale scores and three generic indices of quality of life. It was expected that conceptually related scales would correlate substantially. All correlations were statistically significant (P < 0O01). The correlations between the PDQL scores and the generic quality of life indices (the MOS-24 subscales, the social support survey, and the CES-D depression scale) exceeded the 040 criterion for conceptually related scales for seven of the nine hypothesised subscales. High correlations were found between the physical subscales and the parkinsonian and systemic symptoms, except for the correlations with physical pain. Highest correlations were between the emotional function scale of the PDQL and both the mental health subscale of the MOS and the depression scale. The social function subscale had high correlations with the social functioning scales of the MOS, but not with the social support survey.
Convergent validity
Discussion
We have developed a quality of life instrument for patients with Parkinson's disease which examines parkinsonian symptoms, systemic symptoms, emotional functioning and social functioning. The PDQL has several advantages over existing measurements of functional state. Items were generated from statements about disease related problems of daily living made by patients and neurologists and from a review of the medical literature. Other patients identified which items of impairment of their quality of life were most important to them. These items were incorporated in the questionnaire. This selection process ensures that questionnaire items concentrate on areas of dysfunction most important to patients with Parkinson's disease. The questionnaire is given directly to the patients. Whereas existing disease specific measures focus on tremor or rigidity, our questionnaire also includes other major aspects of dysfunction. The highest scores were in items relating to parkinsonian symptoms, systemic symptoms, and some aspects of emotional function. On average, social problems were scored as less prevalent and important.
The questionnaire is appropriate for most patients with Parkinson's disease, but cannot be given to those with significant cognitive impairment (less than 1% in our sample). We found that patients with Parkinson's disease took about twice as long to fill in the same questionnaires as patients with inflammatory bowel disease.27 Nevertheless, most patients (85%) were willing to participate. Most respondents (69 9%) completed the questionnaire by themselves.
Internal consistency (reliability) of the questionnaire was well above accepted levels. The questionnaire differentiated across three clinical groups as predicted. Mobile and independent patients have better quality of life scores than slightly dependent patients and slightly dependent patients have better quality of life scores than dependent patients who need help or care. Whether it can also discriminate between normal subjects and those with Parkinson's disease is not relevant as this is not the purpose of the instrument. Severity of disease, however, was scored by the patient and not by the neurologist. It is therefore possible that the patient's score on the Schwab and England scale reflected the patient's quality of life rather than disease severity, although the wording of the Schwab and England questionnaire focused solely on the activities of daily living and did not refer to quality of life.
As expected, the PDQL correlated with established generic measures of quality of life: the MOS-24 quality of life scale, and the CES-D depression scale. It can be assumed that they reflect similar constructs and domains of quality of life. Therefore, the PDQL is a valid instrument.
The results reported here require confirmation by other investigators. More research has to be done to see how the PDQL will behave longitudinally. The PDQL takes only a few minutes to administer. We therefore recoimend that investigators interested in determining the effects of their interventions on quality of life in patients with Parkinson's disease should give the PDQL as a disease specific questionnaire. As a time specification we used three months, because of the chronic nature of Parkinson's disease, but this could be modified according to the study.
In conclusion, 8 . difficulties in doing sport or leisure activities (Soc) 9 . clumsiness (P) 10 . feeling embarrassed because of your illness (E) 11 . shuffling (P) 12. having to postpone or cancel social activities because of your illness (Soc) 13 . a feeling of extreme exhaustion (Sys) 14 . difficulties turning around while walking (P) 15 . being afraid of possible progressing of the illness (E) 16 . difficulties writing (P) 17 . being less able to go on holiday than before your illness (Soc)
18. feeling insecure of yourself around others (E) 19 . difficulties getting a good night's rest (Sys) 20 . "on/off' periods (P) 21 . difficulty with accepting your illness (E) 22 . difficulties talking (P) 23 . difficulties signing your name in public (Soc) 24 . difficulties walking (Sys) 25 . drooling (P) 26 . feeling depressed or discouraged (E) 27 . difficulty with sitting still (for long periods) (P) 28 
